Antares Pharma, Inc.

NJ · United States · Reporting entity ID 100000076367

Total reported 2019–2025

$4.95M

#709 of 2,960 reporting companies — 0% of all reported industry payments

$3.61M in general payments across 111,977 records, plus $1.34M in research funding across 125 records.

How it breaks down

General payments $3,609,902

Research funding $1,336,543

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.